BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 18, 2016
View Archived Issues
Sumitomo Dainippon Pharma reviews highlights of fourth quarter of fiscal 2015
Read More
Sanofi Genzyme and Johns Hopkins School of Medicine to collaborate on multiple sclerosis
Read More
REGENXBIO enters agreement with Biogen for gene therapy treatments against rare vision disorders
Read More
TopiVert finishes preclinical development of TOP-1630
Read More
Astellas reflects on milestones of fourth quarter of fiscal 2015
Read More
Infant Bacterial Therapeutics opens phase II trial of IBP-9414 to prevent necrotizing enterocolitis
Read More
Upsher-Smith Laboratories begins first clinical trial of USL-311
Read More
Inovio Pharmaceuticals' Zika vaccine shows promise in nonhuman primates
Read More
CDK9 inhibitor AZ-5576 is potent, selective and orally active
Read More
ME-401 well tolerated in healthy subjects, study in patients planned
Read More
Dong-A ST patents GDIR agonists
Read More
F. Hoffmann-La Roche discloses cytochrome P450 11B2 inhibitors
Read More
Redx Pharma describes antibacterial agents
Read More
RaQualia Pharma presents GHS receptor agonists
Read More
A1M Pharma initiates A1M-based research collaboration with CSL Behring
Read More
Shionogi develops AMPK activators
Read More
Cancer immunotherapy uses T cells expressing inducible MyD88/CD40 and targeted T-cell receptors
Read More
Bone Therapeutics reports results from phase I/II trial of ALLOB
Read More
European Commission approves Uptravi for pulmonary arterial hypertension
Read More
Eisai transfers ownership of AkaRx and worldwide rights to avatrombopag
Read More
FDA grants accelerated approval to nivolumab for patients with classical Hodgkin's lymphoma
Read More
Novo Nordisk submits BLA for nonacog beta pegol
Read More
Boehringer Ingelheim's olmunitib receives approval in South Korea
Read More
GVK Biosciences reports development of selective PI3Kbeta inhibitors
Read More
Onzetra Xsail launched in U.S.
Read More
Mabtech completes phase II/III study for STI-004
Read More
FDA grants orphan drug designation to VM-202 for ALS
Read More
New CDC7 inhibitor shows broad antitumor activity in vivo
Read More